Current methods for mapping cell surface structures are time-consuming and lack the precision needed for effective development of targeted cell therapies. Inaccurate identification of tumor cells limits the efficacy of cancer treatments and hinders the creation of personalized therapies.

The company offers a biotech platform that combines generative artificial intelligence and advanced photonics to create detailed maps of cell surface structures. This platform enables researchers to precisely identify and characterize tumor cells, leading to the development of more effective and targeted cell therapies. By providing a high-resolution view of cell surfaces, the technology facilitates the discovery of novel biomarkers and therapeutic targets. The platform accelerates the development cycle for cell therapies, reducing the time and cost associated with traditional methods.

Generative AI algorithms for predicting and modeling cell surface structures

Advanced photonics technology for high-resolution imaging of cell surfaces

Automated cell identification and characterization

Integrated data analysis and visualization tools

Customizable workflows for different cell types and applications

The primary target audience includes biotech companies, pharmaceutical researchers, and academic institutions involved in cell therapy development and cancer research.